Immunai and Teva partner to innovate new cancer, immunology therapies
The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.(photo credit: AMIR COHEN/REUTERS)
